A new study by UT Southwestern scientists indicates that an
The enzyme that could help 700 million people worldwide
University of South Australia researchers have identified an enzyme that
Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to
CAL20.C SARS-CoV-2 variant skyrocketing in California evades host immune response
The effect of different neutralizing antibodies, both vaccine-elicited and from
Research suggests toothpaste and mouthwash ingredients could help prevent SARS-CoV-2 infection
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model
The emergence of new strains of the severe acute respiratory
How does the SARS-CoV-2 E484K mutation increase viral fitness?
How do mutations benefit severe acute respiratory syndrome coronavirus 2
A glycan controls how SARS-CoV-2’s spike protein opens, study finds
Using simulations, a team of researchers in the U.S. found
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2
Researchers from Cuba, China, and France have demonstrated the potential
Gene Targets for in Utero Therapy in Down Syndrome: Potentials and Pitfalls
By Keynote ContributorProf. Ahmad Salehi, M.D, Ph.DClinical Professor with Stanford